“Predicting osteoradionecrosis risk in patients with locoregionally advanced nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: The value of the CARWL index” (2024) Biomolecules and Biomedicine, 25(1), pp. 240–248. doi:10.17305/bb.2024.11155.